E

Enlivex Therapeutics Ltd
D

ENLV

1.15000
USD
0.03
(2.68%)
مغلق
حجم التداول
2,910
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
272,988,723
أصول ذات صلة المقالات

العنوان: Enlivex Ltd.

القطاع: Healthcare
الصناعة: Biotechnology
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.